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Abstract Ligation of proteins to ubiquitin requires activation
of ubiquitin by E1, the ubiquitin-activating enzyme. Mutant
alleles of E1 in mammalian cells have been crucial for dissecting
the contribution of the ubiquitin system to cell function.
Comparable mutants have been unavailable for Saccharomyces
cerevisiae. Here we describe the isolation and characterization
of a hypomorphic allele of S. cerevisiae E1. Protein modification
by ubiquitin is strongly impaired in the mutant, inhibiting
degradation of ubiquitin^proteasome pathway substrates as
well as ubiquitin-dependent but proteasome-independent degra-
dation of membrane receptors. This allele will be a useful tool
for evaluating the ubiquitin-dependence of cellular processes
in yeast, even those in which the proteasome is not in-
volved. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Ubiquitin is a 76-residue polypeptide that has been impli-
cated in a steadily increasing number of cellular processes [1^
3]. The protein is synthesized in precursor form, being made
either as a head-to-tail array of ubiquitin units or as a fusion
to certain ribosomal proteins. The translational fusion of
ubiquitin to these ribosomal proteins is required for normal
ribosome biogenesis [4], although the ubiquitin moieties are
cotranslationally removed by cellular deubiquitinating en-
zymes. All known post-translational functions of ubiquitin
require its enzymatic ligation to target proteins. Covalent at-
tachment occurs via an enzymatic cascade that begins with the
activation of the C-terminal carboxyl group of ubiquitin by a
ubiquitin-activating enzyme or E1 [3]. This ATP-dependent
reaction results in a high-energy thioester bond between ubiq-
uitin and E1. The ubiquitin is then transferred via transthio-
lation to a ubiquitin-conjugating enzyme or E2. With the aid
of a ubiquitin^protein ligase, or E3, ubiquitin is attached to a
target protein by an amide bond between the C-terminus of
ubiquitin and an acceptor lysine side chain in the target pro-
tein.
Ligation of ubiquitin to a substrate can have a variety of
consequences. For many proteins, a polyubiquitin chain is
assembled on a substrate lysine residue(s) ; this chain binds
with high a⁄nity to the 26S proteasome [5], leading to the
degradation of the substrate into small peptides and recycling
of the ubiquitin moieties. Ubiquitination of over a dozen cell
surface membrane proteins has also been reported, and the
modi¢cation is necessary for their internalization and trans-
port to the vacuole, where the proteins are destroyed in a
proteasome-independent manner [6^8]. Interestingly, for ubiq-
uitin-dependent endocytosis, either monoubiquitination or a
short chain of ubiquitins linked by their Lys-63 side chains is
su⁄cient for internalization [9,10]. Functional alteration by
ubiquitin ligation of other proteins, e.g. certain histones, has
been suggested as well, but the mechanistic consequences of
these modi¢cations are not well understood [11].
The ¢rst evidence for the physiological importance of the
ubiquitin system came from seminal genetic studies with a
temperature-sensitive mouse cell line that harbored a thermo-
labile E1 enzyme [12,13]. Although analysis of the Saccharo-
myces cerevisiae ubiquitin system has subsequently had a
prominent role in uncovering the many physiological func-
tions of protein ubiquitination [1,14,15], it has still often
been di⁄cult to link a particular metabolic process to protein
ubiquitination in this organism. This limitation can be traced
to the fact that ubiquitin^protein conjugates are often very
di⁄cult to detect and because no partial loss-of-function mu-
tants are available in the essential yeast E1 gene, UBA1. Eval-
uating the e¡ects of di¡erent E2 or UBC mutations on a
protein or process is possible (e.g. [16]) but is laborious in-
asmuch as yeast cells have 11 di¡erent E2 enzymes that are
targets for ubiquitin transfer from Uba1. At least as many E3
ligases are anticipated, so E3 mutants are also not an e⁄cient
route for determining the involvement of ubiquitin ligation in
a process of interest.
Here we describe a new hypomorphic allele of UBA1 that
strongly impairs ubiquitin^protein ligation in S. cerevisiae. All
tested ubiquitin-dependent processes were shown to be defec-
tive in this mutant. The pathways examined include ubiquitin-
mediated receptor endocytosis, which does not require the
proteasome. Therefore, this uba1 allele should be of general
utility in evaluating ubiquitin-dependence of a process in
yeast, particularly in cases where the proteasome is not in-
volved.
2. Materials and methods
2.1. Yeast and bacterial media and methods
Yeast rich (YPD) and minimal (SD) media were prepared as de-
scribed, and standard yeast genetic methods were used [17]. Strains
used for mutagenesis were MHY102 (MatK ura3-52 lys2-801 leu2-3,
112: :LEU2-v68-210K2-lacZ) [18] and the congenic MHY113 (MATa
ura3-52 lys2-801 leu2-3,112: :LEU2-v68-210K2-lacZ). MHY1409
(MATK his3-v200 leu2-3,112 ura3-52 lys2-801 trp1-1 uba1-2) was
made by backcrossing the original uba1-2 strain to MHY501
(MATK his3-v200 leu2-3,112 ura3-52 lys2-801 trp1-1) [16] four times.
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Escherichia coli strains used were JM101 and Electromax DH 10B,
and standard techniques were employed for recombinant DNA work
[19].
2.2. Isolation of uba1-2
The haploid yeast strains MHY102 and MHY113, which contain
the integrated Deg1-L-galactosidase (Deg1-Lgal)-encoding construct,
were mutagenized using a mini-transposon library as described
[20,21]. Brie£y, mTn-3xHA/GFP transposon-mutagenized yeast frag-
ments [21] were released from a holding vector by digestion with NotI
and transformed into MHY101 and MHY113 using standard tech-
niques. Mutagenized yeast was then selected on synthetic medium
lacking uracil (SD3ura). After 2^3 days of growth, yeast was repli-
ca-plated onto SD3ura medium containing the chromogenic substrate
X-gal [22] and grown for 2^3 days at 30‡C. Colonies which rapidly
turned dark blue were picked and re-screened on X-gal-containing
plates. LGal activity was then quantitatively measured in these strains
in liquid media using ortho-nitrophenyl galactoside (ONPG) as the
substrate. Pulse-chase analysis [16] of Deg1-Lgal degradation was
done for the mutants that remained in order to verify directly a defect
in Deg1 fusion protein proteolysis.
The location of the mTn-3xHA/GFP insertions was ascertained by
Vectorette PCR (http://genome-www.stanford.edu/group/botlab/pro-
tocols/vectorette.html). Brie£y, yeast genomic DNA was isolated
from the mTN-mutated strain and cut with AluI. The restriction en-
zyme was heat-inactivated, and the digested genomic DNA was an-




TCCTCTCCTTC-3P. PCR ampli¢cations were performed on the
ligation mixture using the universal primer (5P-CGAATCGTA-
ACCGTTCGTACGAGAATCGCT-3P) and a primer to the GFP se-
quence on the transposon (5P-CATCACCTTCACCCTCTCCACT-
GAC3P). The isolated PCR product was then sequenced.
2.3. Measurements of protein half-life and immunoblot analysis
Pulse-chase analysis was carried out as described [16] except that
quantitation was done on a phosphorimager. Immunoprecipitations
of K2 were performed with anti-K2 antibodies [18], those of a1 with an
anti-a1 antibody [23]. Immunoprecipitations of Lgal were done using
anti-Lgal antibodies (Cappel, West Chester, PA, USA).
To follow the stability of Ste3, a ‘cycloheximide-chase’ protocol was
used [24,25]. Cycloheximide was added to a concentration of 50 Wg/ml
to cells grown in minimal medium to an OD600 of 1. Extracts were
then made from aliquots of cells taken at the desired time points by
heating to 100‡C in Laemmli SDS gel-loading bu¡er. After spinning
out debris, samples were electrophoresed on SDS^polyacrylamide gels
and transferred to Immobilon-P membranes (Millipore, Bedford, MA,
USA). Blots were incubated with anti-Ste3 antibodies [26] in TBST
bu¡er containing 1% non-fat dried milk [25]. Antibody binding was
detected using ECL reagents from Amersham (Arlington Heights, IL,
USA). Western immunoblot analysis of cellular ubiquitin levels was
performed as above using anti-ubiquitin antibodies [25].
2.4. Northern RNA hybridization analysis
Total RNA was puri¢ed from yeast cells using the Purescript RNA
isolation kit (Gentra Systems; Research Triangle Park, NC, USA),
and Northern RNA hybridization was performed as described [19].
12 Wg of RNA from each sample were loaded in each lane. The DNA
probe used to detect UBA1 was a 756-bp NsiI fragment [27], which
was radiolabelled with [K-32P]dATP using a random-primed DNA
labeling kit (Boehringer Mannheim, Indianapolis, IN, USA). The
probe used to detect the actin mRNA was a radiolabeled 560-bp
ClaI fragment from the yeast ACT1 gene.
3. Results
3.1. Isolation of a viable uba1 mutant
As part of our studies on the mechanisms of ubiquitination
and degradation of the yeast MatK2 repressor, the ¢rst iden-
ti¢ed ubiquitin^proteasome pathway substrate in yeast
[18,28,29], we conducted a genetic screen to identify novel
genes involved in its degradation. The ¢rst 67 amino acids
of K2 include a ubiquitin-dependent degradation signal called
Deg1, which when fused to the E. coli L-galactosidase (Lgal)
protein (Fig. 1A) caused rapid degradation of the resulting
fusion protein in yeast. If yeast cells expressing the short-lived
Deg1-Lgal reporter were plated on medium containing the
chromogenic substrate X-gal, the resulting colonies were white
or pale blue. However, if the strain was compromised for
Deg1-Lgal degradation, the fusion accumulated to high levels,
yielding dark blue colonies on X-gal. A similar screen had
been conducted previously to identify the original degradation
of alpha2 (doa) mutants [18] (see Fig. 1B), but we had not
identi¢ed any candidate E3 genes nor had we isolated several
genes known to be required for Deg1-mediated ubiquitination,
Fig. 1. Isolation of the uba1-2 allele. A: Schematic of the Deg1K2-Lgal fusion construct used for the genetic screen described in B. B: Outline
of the genetic screen used to isolate the uba1-2 allele. C: Pulse-chase analysis of Deg1-Lgal in wild-type and uba1-2 cells. The proteins were pre-
cipitated by an antibody to Lgal. D: Plot of Deg1-Lgal degradation from C.
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viz., CUE1 and UBC7. The new screen was di¡erent in two
ways. First, the reporter construct was integrated into the
chromosome to provide more reliable color development on
X-gal. Second, instead of using chemical mutagenesis, we used
transposon mutagenesis, which facilitated subsequent identi¢-
cation of the a¡ected genes.
Approximately 90 000 yeast cells that had been transformed
with a mini-transposon (mTn3)-mutagenized yeast genomic
DNA library [21] were screened for potential defects in
Deg1-Lgal degradation. Mutants that formed dark blue colo-
nies on X-gal plates had their Lgal activity measured quanti-
tatively in liquid cultures with the ONPG substrate to elimi-
nate false positives. The presence of single insertions and
cosegregation of insertions with the apparent proteolytic de-
fect were determined by backcrossing to a non-mutagenized
strain and tetrad analysis. The mTn3 insertion sites were de-
termined by PCR ampli¢cation of the genomic inserts and
DNA sequencing (Table 1). Fifteen recessive mutants re-
mained after these tests and were sequenced. Eleven had
mTn3 insertions in the open reading frame of the non-essen-
tial RPN4/SON1 gene; another RPN4 insert was sequenced
from a mutant with a dominant degradation defect, but link-
age of the degradation defect to the mTn3 insertion was not
veri¢ed. Rpn4 may be a subunit of the 19S regulatory particle
of the proteasome but it also functions as a transcription
factor that controls the expression of proteasome genes [30^
32]. Two of the remaining mutants had transposon insertions
in the UBP14 gene, which encodes a deubiquitinating enzyme
that disassembles unanchored ubiquitin chains and was
known to be required for maximal K2 degradation rates
[33]. Finally, two mutants had identical insertions 84 bp up-
stream of the translational start site of UBA1. By pulse-chase
analysis, this mutation, which we call uba1-2, caused a
Vfour-fold decrease on Deg1-Lgal degradation rate (Fig.
1C,D).
No viable yeast uba1 mutant alleles had previously been
identi¢ed. Because all post-translational functions of ubiquitin
require its covalent attachment to speci¢c proteins and be-
cause this modi¢cation universally requires the activation of
ubiquitin by Uba1, the uba1-2 mutant might provide a useful
tool for research on the ubiquitin system and was therefore
further characterized.
3.2. uba1-2 alters sensitivity to various environmental stresses
The ubiquitin system is involved in a broad range of cellular
processes, many of which are essential for growth. Mutations
compromising the ubiquitin system have been shown to lead
to poor growth and to stress sensitivities. The uba1-2 mutant
had a marked growth defect at 30‡C (Fig. 2A). Surprisingly,
this growth defect is not only not exacerbated at higher tem-
peratures, but the mutant strain actually grows as well as if
not better than wild-type yeast at 37‡C (Fig. 2B) and grows
substantially better than wild-type at 38‡C (Fig. 2C). Mutant
uba1-2 cells also had no discernible growth defect at 15‡C
relative to the congenic wild-type strain (Fig. 2D). It is im-
portant to note that the mutant growth rate at the low and
high temperatures does not exceed the rate seen for the mu-
tant at 30‡C. The amino acid analog canavanine (1 Wg/ml) did
not worsen the uba1-2 growth defect at 30‡C (data not
shown), but uba1-2 cells were extremely sensitive to the heavy
metal cadmium (Fig. 2E). Thus, uba1-2 has a complex re-
sponse to di¡erent environmental conditions (see Section 4).
3.3. uba1-2 reduces wild-type Uba1 protein function
The insertion of the mTn3 transposon upstream of the
translational start site of UBA1 in uba1-2 cells should not
alter the encoded Uba1 protein itself, but it may reduce
Uba1 levels to a point where ubiquitin activation becomes
rate-limiting for certain ubiquitin-dependent processes. We
do not have antibodies against Uba1, so we compared the
Table 1
Genes identi¢ed in mTn3 insertion screen




Fig. 2. The uba1-2 mutation alters yeast growth and stress sensitiv-
ities. A: Wild-type and uba1-2 cells were grown in liquid rich me-
dium (YPD) to an OD600 of 1, spotted in 10-fold serial dilutions
onto a YPD plate, and grown for 1 day at 30‡C. B: As in A except
cells were grown for 4 days at 37‡C. C: As in A except cells were
grown for 4 days at 38‡C. D: As in A except cells were grown for
6 days at 15‡C. E: As in A except cells were grown for 5 days on
minimal medium containing 30 WM CdCl2.
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UBA1 mRNA transcript in wild-type and mutant cells by
Northern RNA hybridization analysis (Fig. 3A). In wild-
type cells, UBA1 mRNA was easily detected. Surprisingly,
however, even prolonged exposure to ¢lm did not reveal the
presence of a transcript in uba1-2 cells that hybridized with
the internal UBA1 probe. The 5P end of the UBA1 transcript
has never been mapped, so it is conceivable that the trans-
poson insertion alters the UBA1 transcript itself, perhaps gen-
erating a very large transcript that does not transfer well
during the Northern blotting procedure and/or has reduced
metabolic stability.
Reduced Uba1 protein function should be detectable as a
decrease in ubiquitin^protein ligation in uba1-2 cells. To test
this, wild-type and uba1-2 cells were compared by anti-ubiq-
uitin immunoblot analysis. Indeed, the uba1 hypomorph
showed a striking drop in bulk ubiquitin^protein conjugates
and a corresponding increase in free ubiquitin compared to
the wild-type strain (Fig. 3B). The only previously isolated
yeast ubiquitin system mutant that showed such a general
decrease in ubiquitin^protein conjugation was the ubc4v-
ubc5v strain [34]. However, the latter strain is defective in
only a limited set of ubiquitin-dependent pathways, e.g. it is
not signi¢cantly impaired for Deg1-Lgal degradation.
3.4. uba1-2 is defective in multiple ubiquitin-dependent
molecular processes
For uba1-2 to have broad utility in evaluating ubiquitin
system function in yeast, the mutant should cause a general
dysfunction in ubiquitin conjugation that is measurable by
defects in a wide range of ubiquitin-dependent processes.
We therefore measured the rate of degradation of a diverse
series of ubiquitin system substrates. Leu-Lgal is a short-lived
model protein that is targeted via N-end rule-mediated ubiq-
uitination to the proteasome (Fig. 4A) [15]. Ub-Pro-Lgal is
another short-lived test substrate that is ubiquitinated by E2
and E3 enzymes that are distinct from those that act on Leu-
Lgal or Deg1-Lgal. Both Leu-Lgal and Ub-Pro-Lgal were sta-
bilized Vthree-fold in the uba1-2 strain (Fig. 4B). Finally, the
short-lived transcriptional regulators K2 and a1 [35] were also
modestly stabilized in uba1-2 cells (data not shown).
We also asked whether defects in proteasome-independent
but ubiquitin-dependent processes could be detected in the
uba1-2 mutant. Ste3 is the a-pheromone receptor which,
when ubiquitinated, is internalized and transported by the
endocytic pathway to the vacuole, where it is degraded by
vacuolar proteases [26]. If uba1-2 lowers the rate of Ste3 ubiq-
uitination, Ste3 endocytosis should be impaired, which can be
followed indirectly by measuring the rate of vacuolar hydro-
lase-dependent Ste3 degradation. Levels of total Ste3 were
measured by anti-Ste3 immunoblotting at various times after
protein translation had been blocked in wild-type and mutant
cells (Fig. 4C). Ste3 was degraded signi¢cantly more slowly
(2^3-fold) in the uba1-2 strain than in the congenic wild-type
strain.
4. Discussion
4.1. Isolation of ubiquitin^proteasome pathway mutants
The mutant screen described here has led to the identi¢ca-
tion of mutations in three yeast genes, all which were previ-
ously implicated in ubiquitin-dependent protein degradation.
It is clear that there were strong biases in the types of mutants
we were able to isolate. Three-fourths of the mutants were in
a single gene, RPN4. Moreover, no inserts in novel genes or in
other genes known to be important for Deg1-mediated degra-
dation (e.g. UBC6, UBC7, CUE1, DOA1, DOA4 ; see [29])
were identi¢ed. We also identi¢ed numerous inserts in the
ribosomal RNA locus, but these inserts did not cosegregate
with the Deg1-Lgal degradation. The mTn3 transposon libra-
ries are now recognized to have strong insertion-site prefer-
ences.
Despite the failure to identify any new genes involved in
Deg1-dependent proteolysis by the current screen, we have
identi¢ed what should be a very useful hypomorphic allele
Fig. 3. UBA1 transcript and function in uba1-2 cells. A: Northern
analysis of UBA1 in wild-type cells and uba1-2 cells. A probe recog-
nizing the actin (ACT1) mRNA was used to verify similar RNA
loading in each lane. B: Anti-ubiquitin immunoblot analysis of
wild-type and uba1-2 cells. The antibody used was a polyclonal anti-
serum that had been a⁄nity-puri¢ed on a ubiquitin a⁄nity resin.
Fig. 4. uba1-2 is impaired in a variety of ubiquitin related processes.
A: Pulse-chase analysis of degradation of Leu-Lgal in wild-type and
uba1-2 cells. B: Pulse-chase analysis of degradation of Ub-Pro-Lgal
in wild-type and uba1-2 cells. C: Immunoblot analysis of Ste3 deg-
radation in wild-type and uba1-2 cells. Protein synthesis was blocked
at t = 0 min by addition of 50 Wg/ml cycloheximide.
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of the essential yeast gene UBA1. This allele, uba1-2, contains
a mTn3-based transposon inserted 84 bp upstream of the
translational start site of UBA1. Northern RNA hybridization
analysis failed to detect the UBA1 mRNA in uba1-2 cells. It is
unclear based on these experiments whether the transposon
only lowers transcription rates of wild-type UBA1 mRNA or
also alters the UBA1 mRNA in a way that reduces translation
rates and/or mRNA stability. In either case, the coding se-
quence for the Uba1 protein is intact, suggesting that the
uba1-2 defects in ubiquitin-dependent pathways are due to
insu⁄cient amounts of otherwise normal Uba1 protein in
the cell. This idea is consistent with the ubiquitin^protein
conjugate pro¢le in the mutant, which shows both increased
monomeric ubiquitin and decreased levels of conjugated ubiq-
uitin.
4.2. Paradoxical growth e¡ects of uba1-2
The ubiquitin system is known to be essential for growth in
yeast and to participate in the response to a variety of stresses
such as heat shock. Under optimal growth conditions, uba1-2
cells have a marked growth defect compared to wild-type cells
(Fig. 2). At high temperatures, however, the mutant grows
as well as or better than the wild-type strain. One explanation
for this anomaly is that at high temperatures, proteins essen-
tial for yeast growth may partially unfold and be recognized
as substrates for the ubiquitin system. Such proteins might be
rapidly degraded in wild-type yeast, causing a signi¢cant slow-
ing of growth. By this model, these proteins would be less
prone to degradation in the uba1-2 strain due to the scarcity
of Uba1 protein, allowing their continued (partial) function
or possibly, their refolding to functional form, particularly
after heat shock-induced molecular chaperones have accumu-
lated.
The uba1-2 phenotype di¡ers strikingly from that of the
yeast ubi4v mutant, which lacks the stress-inducible polyubiq-
uitin gene [36] and might have been expected to be fairly
similar in phenotype. ubi4v strains grow well at 30‡C but
fail to form colonies at high temperature or in the presence
of amino acid analogs, in contrast to uba1-2 cells. Several
explanations could, in principle, reconcile these seemingly
contradictory data. One possibility is that non-covalently
bound ubiquitin can function to some extent in place of con-
jugated forms in cells under stress conditions. The uba1-2
strain has ample free ubiquitin, whereas the ubi4v strain is
depleted for the unconjugated form. Alternatively, the ubi4v
mutant may simply have a more severe loss of ubiquitin con-
jugation capacity, preventing the ubiquitination and degrada-
tion of toxic proteins that uba1-2 cells can still degrade su⁄-
ciently rapidly. Finally, in the stress sensitivity measurements,
the mutants are grown at 30‡C and then shifted to stress
conditions. The uba1-2 mutant, unlike ubi4v, is strongly
growth compromised at 30‡C so it may undergo an adaptive
response related to acquired thermotolerance, which would
allow it to survive better upon subsequent exposure to certain
environmental insults.
Interestingly, no discernible growth defect is seen at 15‡C
relative to wild-type cells. One possible explanation for this is
that yeasts grow very slowly at this temperature. In optimal
growth conditions, the ubiquitin conjugation system may be
working close to capacity to support maximal growth rates. If
Uba1 protein becomes scarce, as in the uba1-2 strain, a sig-
ni¢cant growth defect would be observed. At lower temper-
atures, however, growth occurs much more slowly, and ubiq-
uitin system activity may not need to be as vigorous as at
optimal growth temperatures. In this case, the decreased
amount of Uba1 protein in uba1-2 would have little or no
e¡ect on the growth rates compared to wild-type yeast. These
ideas remain to be examined experimentally.
4.3. Use of uba1-2 to study ubiquitin system function
All substrates of the ubiquitin-mediated, 26S proteasome-
dependent degradation pathway that we tested showed de-
creased degradation rates in the uba1-2 mutant. Moreover,
the Ste3 a-factor receptor, which requires ubiquitination in
order to be internalized and subsequently destroyed by vacu-
olar proteases, also was degraded more slowly in the mutant,
implying that endocytosis of this protein is impaired by uba1-
2. These data indicate that the ubiquitin-dependence of a cel-
lular pathway can be reliably gauged in this strain. False-neg-
ative results are still possible with such a partial loss-of-func-
tion allele, but we have not yet observed this for any processes
that are known to require ubiquitination.
We believe comparisons between wild-type and uba1-2 mu-
tant strains will be a logical ¢rst step in any test of ubiquitin
system involvement in a particular physiological function in
yeast. For example, the ornithine decarboxylase (ODC) pro-
tein in mammalian cells is degraded by the 26S proteasome,
but this does not require ubiquitination [37]. In yeast, the 26S
proteasome is also required for ODC proteolysis [38], but the
ubiquitin-dependence of this degradation could not be readily
tested. The uba1-2 strain would be ideal for this. Similarly,
processes such as protein secretion, nuclear transport, or chro-
matin remodeling, which have not been linked to the ubiquitin
system, might be tested for ubiquitin-dependence by examin-
ing these pathways in uba1-2 cells. Any protein whose degra-
dation mechanism comes under scrutiny could also be pro¢t-
ably analyzed, at least as an initial test, in the hypomorphic
uba1 strain. Suspicion of ubiquitin system involvement often
begins with the observation of additional bands on SDS^poly-
acrylamide gels that are of higher molecular mass than the
protein under investigation. A loss or reduction in such bands
in uba1-2 cells provides a rapid and sensitive test to determine
whether they are likely to be ubiquitinated species.
It is useful to compare the potential utility of the uba1-2
mutant to two other general strategies that have been devel-
oped to study ubiquitin system involvement in various pro-
cesses in yeast. In the ¢rst of these, strains were constructed
that had a single ubiquitin gene under the control of a regu-
latable promoter [39]. Ubiquitination could then be measured
at various times after synthesis of ubiquitin is turned o¡ as
ubiquitin is gradually depleted from cells. The disadvantages
of this approach are that the strain is cumbersome to manip-
ulate, and, more importantly, the measurements are made as
cells are gradually losing viability. The second strategy that
was previously employed was to examine a process of interest
in doa4v cells [25]. Doa4 is a deubiquitinating enzyme [40].
Loss of this enzyme results in signi¢cantly reduced levels of
cellular ubiquitin even under conditions where cell viability is
not reduced. One drawback of using doa4v, however, is that
the mutant is not only defective for ubiquitin homeostasis but
is also impaired for proteasome function, so the basis of a
speci¢c physiological defect in this mutant is not always easy
to decipher. Hence, hypomorphic alleles of UBA1, such as
uba1-2, will permit approaches complementary to and in
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some cases superior to those just described for the investiga-
tion of ubiquitin system function.
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